Welcome to Valicare!
Do you have questions about the GMP compliance of your ATMP? Or are you looking for a turnkey production solution for your ATMP? Take a look at the services our experts offer or contact us directly.
Learn moreEvents where you can meet Valicare experts
-
02 Jun 2022Online ATMP Lecture, 02.06.2022 Dr. Hans-Georg Eckert, Senior GMP Consultant at Valicare GmbH and lecturer at the Fresenius University of Applied Sciences in Idstein, Germany, will give a block lecture on advanced therapy medicinal products (ATMPs) on June 02, 2022.
-
05 Jul 202206 Jul 2022Leipzig / Germany ISPE D/A/CH ATMP Workshop in Leipzig In the workshop "ATMP in the light of Annex 1 DRAFT", discussions will be held together with pharmaceutical companies, machine manufacturers and representatives of the authorities Both technical and regulatory aspects will be taken into account.
News from around the world
Our international press review contains a selection of news and recent articles on advanced therapy medicinal products (ATMPs), chimeric antigen receptor T-cell therapy (CAR), tumor infiltrating lymphocytes (TILs) and bioengineered tissue products (TEPs).
Early Trial Data Show Crispr Cancer Therapy Response
13.05.2022 | Science & Enterprise13 May 2022. Initial results from a clinical trial show non-Hodgkin lymphoma patients receiving low doses of gene-edited T-cells achieve a ...
CRISPR Therapeutics’ CAR-T for Lymphoma Shows Early Promise
12.05.2022 | BioSpaceBiotech Bay
05.12.22 -- Your New EU IDMP Implementation Strategy
12.05.2022 | Pharmaceutical OnlineOn Cell & Gene: The Podcast, Amit Kumar, Ph.D., CEO at Anixa Biosciences, details the progress on their Phase 1 trial for ovarian cancer ...
Repairing tendons with silk proteins
12.05.2022 | Orthopaedic Product NewsSudden or repetitive motion, experienced by athletes and factory workers, for example, increases the risk of tears or ruptures in the ...
A guide to the organ-on-a-chip
12.05.2022 | NatureOrgans-on-chips (OoCs) are systems containing engineered or natural miniature tissues grown inside microfluidic chips. To better mimic ...
On the Prognostic Power of Tumor-Infiltrating Lymphocytes – A Critical Commentary
12.05.2022 | FrontiersIntroduction Tumor-infiltrating lymphocytes can affect cancer progression. Tumor-infiltrating lymphocytes may generally be classified as ...
Recent Advances in Chitosan and its Derivatives in Cancer Treatment
11.05.2022 | Frontiers1 Introduction Cancer has been becoming a life-threatening disease and a major public health problem all over the world, which is one of ...
Scaling Up Cell Therapies Capacity
11.05.2022 | BioPharm InternationalOutsourcing partners are ready to fill the market need for greater cell therapies capacities.
Shining a Spotlight on Nucleic Acid-Based Therapeutics
11.05.2022 | BioPharm InternationalFurther development of nucleic acid-based therapeutics has been accelerated by the recent success of mRNA vaccines.
BioNTech Forges Ahead in Oncology, Infectious Disease
10.05.2022 | PharmaLiveBioNTech Forges Ahead in Oncology, Infectious Disease
Bone Therapeutics is Breaking New Ground in Bone Remodeling
09.05.2022 | BioSpaceBiotech Bay
Neues aus dem Tissue Engineering: Wie der 3D-Druck hilft
09.05.2022 | medizin & technik
Gestärkte Immunzellen für den Kampf gegen Krebs
07.05.2022 | Krebs-Nachrichten
Gut microbiome as a tool in regenerative medicine; Novel approach driven by GN Corp Japan with potentials in neurological illnesses
07.05.2022 | American PressRegenerative medicine uses tools that include cells (stem cells, progenitors, mature adult cells), cell-derived factors (cytokines), and ...
Bispecific Antibodies With Multiple Targets Moving Forward in Multiple Myeloma
06.05.2022 | The Asco PostPoor outcomes are observed in patients with myeloma who are refractory to multiple classes of therapies, with the average patient ...
Valicare – competent, reliable & efficient
You have little time and still want to know what services Valicare GmbH offers?